Download presentation
Presentation is loading. Please wait.
Published byΑἴσων Μανωλάς Modified over 5 years ago
1
Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD by Gérard Socié, Noel Milpied, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger, Felipe Suarez, Mauricette Michallet, Philippe Lewalle, David Liens, Catherine Mathis, Eric Guemas, and Jean-Paul Vernant BloodAdv Volume 3(2): January 22, 2019 © 2019 by The American Society of Hematology
2
Time to OS from random assignment.
Gérard Socié et al. Blood Adv 2019;3: © 2019 by The American Society of Hematology
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.